...
首页> 外文期刊>Cureus. >Medical Expulsive Therapy for Distal Ureteral Stones: Tamsulosin Versus Silodosin in the Turkish Population
【24h】

Medical Expulsive Therapy for Distal Ureteral Stones: Tamsulosin Versus Silodosin in the Turkish Population

机译:输尿管结石的药物排除疗法:坦索罗辛与西洛多辛在土耳其人口中的关系

获取原文

摘要

Introduction Our aim was to contribute?a study that includes a higher patient population to the limited number of studies comparing tamsulosin and silodosin in the treatment of distal ureteral stones. Material and methods Patients who presented with renal colic to the urology emergency clinic and were diagnosed with ureteral stones?and followed-up with conservative treatment between January 2010 and January 2016 were retrospectively screened. According to the inclusion-exclusion criteria, the patients were divided into three groups. Group 1: 150 patients followed with watchful?waiting (WW), Group 2: 156 patients who received 0.4 mg of tamsulosin daily, and Group 3: 159 patients who received 8 mg of silodosin daily. The side effects of the used drugs, duration of stone reduction, and expulsion rates were evaluated and compared separately. Results A total of 465 patients were included in the study. No statistically significant difference was found in terms of age, gender, and stone size among the groups. The patient characteristics and results are shown in Table 1. The differences in stone expulsion rate?between the groups?in the first week were calculated using the?Chi-square test and found to be non-significant (p = 0.155); whereas, the stone expulsion rates between Group 1 versus Group 2 and Group 1 versus Group 3 were found to be significantly different?after the second and third week. Conclusion According to our results, no statistically significant superiority between tamsulosin and silodosin was shown in the treatment of distal ureteral stones in the Turkish population.
机译:引言我们的目的是为有限的研究(其中坦索罗辛和西洛多辛在输尿管远端结石治疗中进行比较)的研究做出贡献,以增加患者人数。资料和方法回顾性筛选2010年1月至2016年1月间在泌尿外科急诊就诊的患有肾绞痛并被诊断出输尿管结石并接受保守治疗的患者。根据纳入-排除标准,将患者分为三组。第1组:150名患者,进行了等待观察(WW);第2组:156名患者,每天接受0.4 mg坦索罗辛治疗;第3组:159名患者,每天接受8 mg西洛多辛治疗。分别评估和比较了所用药物的副作用,结石持续时间和排出率。结果本研究共纳入465例患者。各组之间在年龄,性别和结石大小方面均未发现统计学上的显着差异。患者的特征和结果列于表1。使用卡方检验计算出第一周各组之间石块排出率的差异,发现差异不显着(p = 0.155)。在第2周和第3周之后,第1组与第2组,第1组与第3组之间的排石率有显着差异。结论根据我们的结果,坦索罗辛和西洛多辛在土耳其人群远端输尿管结石的治疗中没有统计学上的显着优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号